Back to Search
Start Over
Boundless Bio to Presented at the 41st Annual J.P. Morgan Healthcare Conference
- Source :
- Plus Company Updates. December 29, 2022
- Publication Year :
- 2022
-
Abstract
- SAN DIEGO: Boundless Bio. a next-generation precision oncology company developing innovative therapeutics directed against extrachromosomal DNA (ecDNA) in oncogene amplified cancers, today announced that its Chief Executive Officer, Zachary Hornby, [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.732058136